These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9882293)

  • 1. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.
    Brennan FR; Bellaby T; Helliwell SM; Jones TD; Kamstrup S; Dalsgaard K; Flock JI; Hamilton WD
    J Virol; 1999 Feb; 73(2):930-8. PubMed ID: 9882293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses.
    Brennan FR; Jones TD; Longstaff M; Chapman S; Bellaby T; Smith H; Xu F; Hamilton WD; Flock JI
    Vaccine; 1999 Apr; 17(15-16):1846-57. PubMed ID: 10217582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
    Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
    J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses.
    Nicholas BL; Brennan FR; Martinez-Torrecuadrada JL; Casal JI; Hamilton WD; Wakelin D
    Vaccine; 2002 Jun; 20(21-22):2727-34. PubMed ID: 12034099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
    Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimaeric plant virus vaccine protects mice against a bacterial infection.
    Brennan FR; Gilleland LB; Staczek J; Bendig MM; Hamilton WDO; Gilleland HE
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2061-2067. PubMed ID: 10463172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J
    Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat.
    Rennermalm A; Li YH; Bohaufs L; Jarstrand C; Brauner A; Brennan FR; Flock JI
    Vaccine; 2001 May; 19(25-26):3376-83. PubMed ID: 11348701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions.
    Ekström J; Hu KF; Bengtsson KL; Morein B
    Vaccine; 1999 Jun; 17(20-21):2690-701. PubMed ID: 10418920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological response to a Staphylococcus aureus fibronectin-binding protein.
    Ciborowski P; Flock JI; Wadström T
    J Med Microbiol; 1992 Dec; 37(6):376-81. PubMed ID: 1460656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulating complexes (ISCOMs) for nasal vaccination.
    Hu KF; Lövgren-Bengtsson K; Morein B
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):149-59. PubMed ID: 11516786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route.
    Medina E; Talay SR; Chhatwal GS; Guzmán CA
    Eur J Immunol; 1998 Mar; 28(3):1069-77. PubMed ID: 9541603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery.
    Cano F; Liljeqvist S; Nguyen TN; Samuelson P; Bonnefoy JY; Ståhl S; Robert A
    FEMS Immunol Med Microbiol; 1999 Aug; 25(3):289-98. PubMed ID: 10459584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.
    Lowell GH; Kaminski RW; VanCott TC; Slike B; Kersey K; Zawoznik E; Loomis-Price L; Smith G; Redfield RR; Amselem S; Birx DL
    J Infect Dis; 1997 Feb; 175(2):292-301. PubMed ID: 9203649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
    Zhang P; Lewis JP; Michalek SM; Katz J
    Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
    Stiles BG; Garza AR; Ulrich RG; Boles JW
    Infect Immun; 2001 Apr; 69(4):2031-6. PubMed ID: 11254555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.